There were 1,852 press releases posted in the last 24 hours and 397,684 in the last 365 days.

Drug Screening Market - Global Forecast to 2022

Dublin, April 04, 2018 (GLOBE NEWSWIRE) -- The "Drug Screening Market by Product, Drug Screening Services, Sample Type, End User - Global Forecast to 2022" report has been added to's offering.

The drug screening market is expected to reach USD 8.63 billion million by 2022 from USD 5.32 billion in 2017, at a CAGR of 10.2%

Growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and the presence of government funding in major markets are factors driving the growth of the drug screening market. On the other hand, market growth may be limited to a certain extent due to the prohibition of workplace drug testing in some countries and the ban on alcohol consumption in several Islamic countries.

Drug screening market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period, growth in this segment is attributed to factors such as the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new and regular service launches and regulatory approvals, and the geographic expansion of drug and alcohol testing laboratories.

The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to dominate the market during the forecast period due to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing consumption of illicit drugs, rising number of drunk-driving cases, growing awareness regarding drug screening tests and the strategic expansion of the market players in the region.

Market Dynamics


  • Growing Drug & Alcohol Consumption
  • Enforcement of Stringent Laws Mandating Drug and Alcohol Testing
  • Presence of Government Funding in Major Markets
  • Regulatory Approvals & Product Launches and Services


  • Ban on Alcohol Consumption in Several Islamic Countries
  • Prohibition of Workplace Drug Testing in Some Countries


  • Oral Fluid Testing
  • Emergence of Fingerprint-Based Drug Screening
  • Emerging Economies


  • Accuracy and Specificity Concerns Related to Breathalyzers

List of companies profiled in the report

  • Alere (US)
  • Thermo Fisher (US)
  • Drgerwerk (Germany)
  • LabCorp (US)
  • Quest Diagnostics (US)
  • Alfa Scientific Designs (US)
  • Lifeloc (US)
  • MPD, Inc. (US)
  • OraSure (US)
  • Omega Laboratories (US)
  • Premier Biotech (US)
  • Psychemedics (US)
  • Roche (Switzerland)
  • Shimadzu (Japan)
  • Seimens Healthineers (US)

Key Topics Covered:

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Secondary Datas
2.3 Primary Data
2.4 Market Estimation
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Attractive Opportunities in Drug Screening Market
4.2 Drug Screening Market, By Product
4.3 Geographical Analysis Europe Drug Screening Market, By Product and Country
4.4 Drug Screening Market, By Sample Type
4.5 Drug Screening Market, By End User
4.6 Drug Screening Market: Geographic Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Dynamics

6 Drug Screening Market, By Product & Service
6.1 Introduction
6.2 Drug Screening Products
6.2.1 Analytical Instruments Immunoassay Analyzers Chromatography Instruments Breathalyzers Fuel Cell Breathalyzers Semiconductor Breathalyzers Other Breathalyzers
6.2.2 Rapid Testing Devices Urine Testing Devices Drug Testing Cups DIP Cards Drug Testing Cassettes Oral Fluid Testing Devices
6.2.3 Consumables Assay Kits Sample Collection Devices Calibrators and Controls Other Consumables
6.3 Drug Screening Services

7 Drug Screening Market, By Sample Type
7.1 Introduction
7.2 Urine Samples
7.3 Breath Samples
7.4 Oral Fluid Samples
7.5 Hair Samples
7.6 Other Samples

8 Drug Screening Market, By End User
8.1 Introduction
8.2 Workplace
8.3 Criminal Justice Systems and Law Enforcement Agencies
8.4 Drug Treatment Centers
8.5 Pain Management Centers
8.6 Schools and Colleges
8.7 Hospitals
8.8 Individual Users
8.9 Drug Testing Laboratories

9 Drug Screening Market, By Region

10 Competitive Landscape
10.1 Introduction
10.2 Rapid Testing Devices, Ranking of Key Player (2016)
10.3 Drug Screening Services Market, Ranking of Key Player (2016)
10.4 Competitive Scenario
10.4.1 Product Launches and Approvals
10.4.2 Expansions
10.4.3 Agreements, Partnerships, and Collaborations
10.4.4 Acquisitions

11 Company Profiles
11.1 Alere
11.2 Thermo Fisher Scientific
11.3 Drgerwerk
11.4 Labcorp
11.5 Quest Diagnostics
11.6 Alfa Scientific Designs
11.7 Lifeloc
11.8 MPD Inc.
11.9 Orasure
11.10 Omega Laboratories
11.11 Premier Biotech
11.12 Psychemedics
11.13 Roche
11.14 Shimadzu
11.15 Siemens Healthineers

For more information about this report visit

         Laura Wood, Senior Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Drug Abuse Screening

Primary Logo